The 6 analysts offering 12-month price forecasts for Itamar Medical Ltd have a median target of 30.00, with a high estimate of 36.00 and a low estimate of 29.00. The median estimate represents a +58.73% increase from the last price of 18.90.
The current consensus among 6 polled investment analysts is to Buy stock in Itamar Medical Ltd. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.16
Reporting Date Aug 18
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.